Nanoparticles for Drug Delivery in Prostate Cancer Treatment
Nanoparticles have emerged as a promising technology in drug delivery systems, particularly in the context of treating complex diseases like prostate cancer. Their unique properties, including small size, large surface area, and the ability to be engineered for specific targeting, make them an ideal candidate for enhancing therapeutic efficacy while minimizing side effects. Nanoparticles are materials that range in size from 1 to 100 nanometers. At this scale, materials exhibit novel physical and chemical properties compared to their bulk counterparts. Researchers have been exploring various types of nanoparticles—such as liposomes, polymeric nanoparticles, and metallic nanoparticles—for their potential to encapsulate drugs and deliver them directly to tumors. A study published in “The Journal of Controlled Release” demonstrated that nanoparticles modified with prostate-specific membrane antigen (PSMA) could effectively target prostate cancer cells. The research highlights how this tar
